Cartilage tissue engineering: adult human mesenchymal stromal cells and collagen biomaterials by Sanjurjo-Rodríguez, Clara et al.
Osteoarthritis and Cartilage. 2014; 22 Suppl.: S154 
Cartilage tissue engineering: adult human mesenchymal stromal 
cells and collagen biomaterials 
C. Sanjurjo-Rodríguez
†‡
, A.H. Martínez Sánchez
†
, T. Hermida-Gómez
†
, I.M. Fuentes
†‡
, 
J. Buján
§
, F.J. De Toro
‡
, S. Díaz-Prado
†‡
, F.J. Blanco
†
 
† INIBIC- Univ. Hosp. of A Coruña (CHUAC), A Coruña, Spain 
‡ INIBIC Dept. of Med., Univ. of A Coruña, A Coruña, Spain 
§ Dept. of Med. Specialties, Univ. of Alcalá de Henares, Madrid, Spain 
Purpose: The purpose was to study chondrogenesis of adult human Mesenchymal Stromal Cells, isolated 
from bone marrow (hBMSCs), when culture on collagen (Col) biomaterials and to evaluate the suitability 
of the neotissue formed to use in Tissue Engineering. 
 
Methods: hBMSCs were cultured during 30 days in chondrogenic medium with Transforming growth 
factor β-3 (TGFβ-3) on the following biomaterials: Col I, Col I+Col II, Col I+ heparan sulphate (HS), Col 
I+Col II+ heparan sulphate (HS), Col I+Col II+ chondroitin sulphate (CHS) and Col I+ heparin (OLH3). 
We have tested growth and cell morphology on the constructs by histochemical and Scanning (SEM) and 
Transmission (TEM) Electron Microscopy. Chondrogenic differentiation was evaluated in all the 
constructs by histochemical and immunohistochemistry analyses and molecular biology. Moreover, Col 
concentration was measured in supernatants along the culture. 
 
Results: Histology showed that hBMSCs have grown through the scaffolds, being the cell percentage 
respect to the total area of the scaffold: >75% in Col I, Col I+Col II, Col I+HS, Col I+Col II+HS, Col 
I+Col II+CHS; < 50% in Col I+OLH3. It was observed a big amount of extracellular matrix (ECM), 
except in Col I+OLH3. ECM from Col I+Col II and Col I+HS showed the higher metachromasia for 
Safranin O proteoglycan staining, whereas Col I, Col I+Col II+HS, Col I+Col II+CHS showed an 
intermediate metachromasia (Figure). Col II immunostaining was highly positive in Col I and Col I+HS 
ECM and positive intracellularly in Col I+Col II, Col I+Col II+ HS, Col I+Col II+CHS (Figure). Col 
I+OLH3 did not show positivity for proteoglycans and Col II. By measurement of relative expression 
levels (REL), COL II gene expression was seen in cells all over the biomaterials, Col I (0.63 REL), Col 
I+Col II (1.00 REL), Col I+HS (0.47 REL), Col I+Col II+HS (0.93 REL), Col I+Col II+CHS (3.57 REL) 
and Col I+OLH3 (5.20 REL). AGG gene expression was higher in Col I+Col II+HS (6.47 REL) 
constructs than in Col I (0.00 REL), Col I+Col II (0.95 REL),Col I+HS (0.17 REL), Col I+Col II+CHS 
(0.00 REL) and Col I+OLH3 (0.00 REL). TEM analysis showed a big amount of mitochondria and 
oval/rounded shape cells (Figure). We could also see oval/rounded cells and ECM by SEM. 
  
Col released (measured as μg/total volume) was detected in all the supernatants, finding the highest 
concentration in Col I+HS biomaterials cultures except at day 21: Col I (137.33), Col I+Col II (0.00), Col 
I+HS (0.00), Col I+Col II+HS (3.33), Col I+Col II+CHS (13.90) and Col I+OLH3 (0.00). 
 
Conclusions: Data showed hBMSCs are able to attach and proliferate on all Col biomaterials, except in 
Col I+OLH3. These cells showed abundant ECM. Analysis showed differentiated cellular phenotype and 
an ECM similar to cartilage, in biomaterials composed by HS. The neotissue formed in the other 
biomaterials showed an intermediate phenotype. The neo-tissue formed in Col and HS biomaterials could 
be useful for cartilage tissue engineering. Acknowledgements: B. Parma (OPOCRIN S.P.A.); CAM 
(S2009/MAT-1472); CIBER BBN CB06-01-0040; Red Gallega de Terapia Celular (REDICENT); SAI-
UDC; CSR is beneficiary of a fellowship from Diputación de A Coruña; P. Esbrit (Fundación Jiménez 
Díaz). 
 
 
 
Figure: Images from the different constructs (columns). Ordered in rows are shown the different analysis: Scanning (SEM) and 
Transmission (TEM) Electron Microscopy, Safranin O staining (SO) and Collagen type II immunostaining (Col II). 
